The delta opioid receptor: a novel therapeutic target for pain and even more ...

被引：0
|
作者：
Gaveriaux-Ruff, C. [1 ]
机构：
[1] Univ Strasbourg, Dept Neurobiol & Genet, INSERM, IGBMC,CNRS,UMR7104,U964, F-67400 Illkirch Graffenstaden, France
来源：
DOULEUR ET ANALGESIE | 2009年 / 22卷 / 04期
关键词：
Opioid receptor; Delta; Chronic pain; Anxiety depression; ANTIDEPRESSANT-LIKE ACTIVITIES; PROTEIN-COUPLED RECEPTORS; RAT MODEL; AGONIST SNC80; NEUROPATHIC PAIN; FUNCTIONAL COMPETENCE; ANTINOCICEPTIVE PROPERTIES; CHRONIC INFLAMMATION; MORPHINE-TOLERANCE; RHESUS-MONKEYS;
D O I：
10.1007/s11724-009-0146-3
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
The delta opioid receptor is a novel target for pain treatment. The delta receptor appears different from the mu receptor as it is poorly effective for acute nociception but becomes more active in pathological situations. The interest for this receptor has increased recently with the identification of novel ligands and the study of its intracellular traffic. In addition, delta receptor activation lowers anxiety and depression. This review presents the recent knowledge on delta opioid analgesia and on the other neurobiological effects of delta receptor activation.
引用
收藏
页码：201 / 209
页数：9
相关论文
共 50 条
  • [41] Pharmacology of nociceptin and its receptor: a novel therapeutic target
    Calo, G
    Guerrini, R
    Rizzi, A
    Salvadori, S
    Regoli, D
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 (07) : 1261 - 1283
  • [42] Novel Dual-Target μ-Opioid Receptor and Dopamine D3 Receptor Ligands as Potential Nonaddictive Pharmacotherapeutics for Pain Management
    Bonifazi, Alessandro
    Battiti, Francisco O.
    Sanchez, Julie
    Zaidi, Saheem A.
    Bow, Eric
    Makarova, Mariia
    Cao, Jianjing
    Shaik, Anver Basha
    Sulima, Agnieszka
    Rice, Kenner C.
    Katritch, Vsevolod
    Canals, Meritxell
    Lane, J. Robert
    Newman, Amy Hauck
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (11) : 7778 - 7808
  • [43] Delta-5-desaturase: A novel therapeutic target for cancer management
    Pang, Lizhi
    Shah, Harshit
    Xu, Yi
    Qian, Steven
    TRANSLATIONAL ONCOLOGY, 2021, 14 (11):
  • [44] PPAR beta/delta is a novel therapeutic target in acute myeloid leukemia
    Hu, Sophia
    Wald, David
    Parameswaran, Reshmi
    CANCER RESEARCH, 2014, 74 (19)
  • [45] Relative efficacies of delta-opioid receptor agonists at the cloned human delta-opioid receptor
    Quock, RM
    Hosohata, Y
    Knapp, RJ
    Burkey, TH
    Hosohata, K
    Zhang, XY
    Rice, KC
    Nagase, H
    Hruby, VJ
    Porreca, F
    Roeske, WR
    Yamamura, HI
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 326 (01) : 101 - 104
  • [46] INVOLVEMENT OF DELTA(1)-OPIOID RECEPTOR ANTAGONISM IN THE ANTITUSSIVE EFFECT OF DELTA-OPIOID RECEPTOR ANTAGONISTS
    KAMEI, J
    IWAMOTO, Y
    SUZUKI, T
    MISAWA, M
    NAGASE, H
    KASUYA, Y
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 251 (2-3) : 291 - 294
  • [47] Therapeutic potentials of NOP and MOP receptor coactivation for the treatment of pain and opioid abuse
    Kiguchi, Norikazu
    Ding, Huiping
    Ko, Mei-Chuan
    JOURNAL OF NEUROSCIENCE RESEARCH, 2022, 100 (01) : 191 - 202
  • [48] Upregulation of delta opioid receptor by meningeal interleukin-10 prevents relapsing pain
    Inyang, Kufreobong E.
    Sim, Jaewon
    Clark, Kimberly B.
    Geron, Matan
    Monahan, Karli
    Evans, Christine
    O'Connell, Patrick
    Laumet, Sophie
    Peng, Bo
    Ma, Jiacheng
    Heijnen, Cobi J.
    Dantzer, Robert
    Scherrer, Gregory
    Kavelaars, Annemieke
    Bernard, Matthew
    Aldhamen, Yasser A.
    Folger, Joseph K.
    Bavencoffe, Alexis
    Laumet, Geoffroy
    BRAIN BEHAVIOR AND IMMUNITY, 2025, 123 : 399 - 410
  • [49] The Nociceptin Receptor System as a Target for Novel Opioid Use Disorder Therapeutics
    Anastasio, Noelle
    Moeller, F. Gerard
    Cunningham, Kathryn
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 464 - 464
  • [50] IMMUNOSUPPRESSION BY DELTA OPIOID RECEPTOR ANTAGONIST
    ARAKAWA, K
    AKAMI, T
    OKAMOTO, M
    AKIOKA, K
    NAKAI, I
    OKA, T
    NAGASE, H
    TRANSPLANTATION PROCEEDINGS, 1993, 25 (01) : 738 - 740
12345